ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Investigation of the Cylex® ImmuKnow® Assay

This study is currently recruiting participants.
Study NCT00569842.   Last updated on July 30, 2008.   Information provided by Indiana University

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Investigation of the Cylex® ImmuKnow® Assay
Official Title  Investigation of the Cylex® ImmuKnow® Assay
Brief Summary

Currently, there is no accurate way of predicting the occurrence of Graft vs Host Disease (GvHD) or infection. The purpose of this study is to analyze blood with the ImmuKnow® Assay to see if doctors can detect which patients are at risk for GvHD and for getting an infection before they occur.

Detailed Description
Study Phase
Study Type  Observational
Study Design  Case-Only, Prospective
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Leukemia
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Hodgkin's Disease
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Aplastic Anemia
Chronic Myelogenous Leukemia
Intervention 
MEDLINE PMIDs
Links Indiana University Simon Cancer Center: Find a Clinical Trial This link exits the ClinicalTrials.gov site
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  30
Start Date  November 2007
Completion Date November 2010
Eligibility Criteria 

Inclusion Criteria:

Patients who are undergoing allogeneic HSCT using a myeloablative preparative regimen for any of the following disorders are eligible:

  1. Acute leukemia
  2. Non-Hodgkin's Lymphoma
  3. Chronic lymphocytic leukemia
  4. Hodgkin's disease
  5. Multiple myeloma
  6. Myelodysplastic Syndromes
  7. Myeloproliferative Disorders
  8. Aplastic Anemia
  9. Chronic myelogenous leukemia
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Lisa Wood, RN     317-274-1781     llwood@iupui.edu    
Contact: Sherif Farag, MD, PhD     317-274-0843     ssfarag@iupui.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00569842
Organization ID 0710-11/IUCRO-0207
Secondary IDs ††
Study Sponsor  Indiana University School of Medicine
Collaborators ††
Investigators 
Principal Investigator:     Sherif Farag, MD, PhD     Indiana University Simon Cancer Center    
Information Provided By Indiana University
Verification Date July 2008
First Received Date  December 5, 2007
Last Updated Date July 30, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers